Drug Shortage Report for MYLAN-HYDROXYUREA
Report ID | 119721 |
Drug Identification Number | 02242920 |
Brand name | MYLAN-HYDROXYUREA |
Common or Proper name | HYDROXYUREA |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROXYUREA |
Strength(s) | 500MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100BT |
ATC code | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-07-29 |
Actual start date | 2020-07-29 |
Estimated end date | 2020-10-13 |
Actual end date | 2020-10-08 |
Shortage status | Resolved |
Updated date | 2020-10-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v23 | 2020-10-14 | French | Compare |
v22 | 2020-10-14 | English | Compare |
v21 | 2020-10-06 | French | Compare |
v20 | 2020-10-06 | English | Compare |
v19 | 2020-09-30 | French | Compare |
v18 | 2020-09-30 | English | Compare |
v17 | 2020-09-14 | French | Compare |
v16 | 2020-09-14 | English | Compare |
v15 | 2020-08-17 | French | Compare |
v14 | 2020-08-17 | English | Compare |
v13 | 2020-08-14 | French | Compare |
v12 | 2020-08-14 | English | Compare |
v11 | 2020-08-12 | French | Compare |
v10 | 2020-08-12 | English | Compare |
v9 | 2020-08-04 | French | Compare |
v8 | 2020-08-04 | English | Compare |
v7 | 2020-07-29 | English | Compare |
v6 | 2020-07-21 | French | Compare |
v5 | 2020-07-21 | English | Compare |
v4 | 2020-07-14 | French | Compare |